Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.35
-2.17 %
$ 1.22 B
Market Cap
-5.0
P/E
BALANCE SHEET
4.34 B
ASSETS
892 M
LIABILITIES
3.44 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Tilray Brands, Inc.
| Current Assets | 678 M |
| Cash & Short-Term Investments | 261 M |
| Receivables | 102 M |
| Other Current Assets | 315 M |
| Non-Current Assets | 3.66 B |
| Long-Term Investments | 39.9 M |
| PP&E | 574 M |
| Other Non-Current Assets | 3.04 B |
| Current Liabilities | 299 M |
| Accounts Payable | 105 M |
| Short-Term Debt | 39 M |
| Other Current Liabilities | 155 M |
| Non-Current Liabilities | 593 M |
| Long-Term Debt | 348 M |
| Other Non-Current Liabilities | 245 M |
Balance Sheet
Millions
| May-2024 | May-2023 | May-2022 | May-2021 | May-2020 | May-2019 | May-2018 | May-2017 | May-2016 | May-2015 | Aug-2014 | Aug-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash & Cash Equivalents | 228.3 | 206.6 | 415.9 | 488.5 | 358.5 | 407.1 | 46.3 | 59.3 | 12.6 | 5.7 | 9.75 K | 23.8 K |
| Short Term Investments | 32.2 | 241.9 | 0 | 0 | 0 | 14.9 | 34.9 | 64.8 | 0 | 0.2 | 0.3 | 0.3 |
| Receivables | 101.7 | 86.2 | 95.3 | 89.8 | 57.0 | 17.5 | 3.4 | 0.8 | 1.8 | 0.9 | 1.15 K | 2.18 K |
| Inventory | 252.1 | 200.6 | 245.5 | 256.4 | 190.6 | 67.6 | 17.2 | 2.9 | 1.6 | 1.4 | 0.0577 | 0.151 |
| Other Current Assets | 63.4 | 37.7 | 46.8 | 48.9 | 24.2 | 10.9 | 39.3 | 1.8 | 0.7 | 0.4 | 0 | 0 |
| Total Current Assets | 677.7 | 773.0 | 803.5 | 883.6 | 651.2 | 577.1 | 150.9 | 133.1 | 16.8 | 8.3 | 0.3 | 0.3 |
| PP&E | 574.3 | 435.6 | 600.5 | 669.0 | 423.3 | 372.4 | 235.1 | 53.8 | 5.6 | 2.9 | 0 | 0 |
| Intangible Assets | 915.5 | 973.8 | 1 277.9 | 1 605.9 | 261.7 | 289.8 | 175.6 | 1.4 | 3.3 | 60 K | 0 | 0 |
| Goodwill | 2 008.9 | 2 008.8 | 2 641.3 | 2 832.8 | 445.5 | 495.1 | 405.4 | 0.9 | 0.9 | 0 | 0 | 0 |
| Long Term Investments | 39.9 | 12.4 | 15.0 | 25.8 | 19.5 | 54.9 | 39.5 | 41.7 | 1.2 | 0 | 0 | 0 |
| Other Long Term Assets | 119.0 | 0.2 | 111.5 | 8.3 | 0.000001 | 15.3 | 12.5 | 1.1 | 1 | 0.2 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| Total Assets | 4 335.3 | 4 307.3 | 5 449.7 | 6 025.4 | 1 801.2 | 1 804.6 | 1 019.1 | 234.5 | 27.8 | 11.5 | 0.3 | 0.3 |
| LIABILITIES | ||||||||||||
| Accounts Payable | 105.4 | 70.8 | 68.6 | 57.7 | 41.2 | 78.2 | 24.4 | 4.4 | 1.0 | 0.8 | 0 | 0 |
| Short Term Debt | 39.0 | 224.3 | 92.6 | 49.6 | 7.5 | 0 | 2.1 | 1.2 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 150.7 | 123.0 | 112.9 | 279.2 | 65.7 | 58.3 | 2.6 | 974 | 0 | 0 | 10.4 K | 11.1 K |
| Total Current Liabilities | 299.2 | 433.0 | 280.3 | 401.2 | 122.8 | 102.4 | 34.0 | 7.7 | 1.0 | 0.8 | 10.4 K | 11.1 K |
| Long Term Debt | 348.4 | 365.9 | 531.2 | 889.1 | 294.7 | 428.7 | 22.0 | 31.8 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 244.5 | 167.4 | 196.6 | 265.8 | 60.2 | 64.8 | 46.0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 90 K | 11.1 | 0.2 | 3.9 | 0 | (72.2) | 7.0 | (8.2) | 0 | 0 | 0 | 0 |
| Total Liabilities | 892.1 | 977.3 | 1 008.3 | 1 560.0 | 475.9 | 523.6 | 109.0 | 31.3 | 1.0 | 0.8 | 10.4 K | 11.1 K |
| EQUITY | ||||||||||||
| Common Stock | 83 K | 66 K | 53 K | 46 K | 1 331.5 | 1 223.4 | 863.9 | 203.6 | 31.4 | 16.3 | 0.3 | 0 |
| Retained Earnings | (2 660.5) | (2 415.5) | (962.9) | (486.1) | (44.1) | 8.9 | 21.3 | (3.1) | (6.4) | (7.0) | (0.1) | 96.4 K |
| Other Accumulative Comprehensive Income/Loss | (43.5) | (46.6) | (20.8) | 152.7 | (0.9) | 88 K | (0.6) | (2.3) | (1.1) | 0 | 0 | 0 |
| Total Equity | 3 443.2 | 3 329.9 | 4 441.4 | 4 465.3 | 1 325.3 | 1 281.0 | 910.1 | 203.3 | 26.8 | 10.7 | 0.3 | 0.3 |
| Total Liabilities and Equity | 4 335.3 | 4 307.3 | 5 449.7 | 6 025.4 | 1 801.2 | 1 804.6 | 1 019.1 | 234.5 | 27.8 | 11.5 | 0.3 | 0.3 |
| SHARES OUTSTANDING | ||||||||||||
| Common Shares Outstanding | 742.6 | 618.0 | 481.2 | 269.5 | 100.5 | 203.5 | 135.0 | 87.4 | 49.0 | 38.0 | 3.3 | 2.3 |